7Baggers
 3 Promising Penny Stocks With Market Caps Over $90M  simplywall.st Fri, 26 Sep 2025 11:08:31 GMT
 Ovid Therapeutics Regains Nasdaq Compliance  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 analysts set ovid therapeutics (nasdaq:ovid) target price at $3.10  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 analysts set ovid therapeutics (nasdaq:ovid) price target at $3.10  MarketBeat Mon, 08 Sep 2025 07:01:33 GMT
 Neurology biopharmas rebound on trial catalysts and Q2 gains  BioWorld MedTech Fri, 05 Sep 2025 07:00:00 GMT
 takeda, ovid to co-develop tak-935 for paediatric epilepsies  FirstWord Pharma Wed, 03 Sep 2025 05:30:33 GMT
 q3 eps forecast for ovid therapeutics decreased by analyst  MarketBeat Mon, 01 Sep 2025 07:00:00 GMT
 ovid news ??  AInvest Mon, 25 Aug 2025 07:00:00 GMT

Ovid Therapeutics Inc
(NASDAQ:OVID) 

OVID stock logo

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and ...

Founded: 2014
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends